SMS Lifesciences India Limited (SMSLIFE) — Capital Reinvestment Ratio
SMS Lifesciences India Limited (SMSLIFE) has a Capital Reinvestment Ratio of 0.45x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rs340.55 Million) in capital expenditures (Rs153.49 Million). See SMS Lifesciences India Limited balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SMS Lifesciences India Limited Capital Reinvestment Ratio (2016–2025)
This chart tracks SMS Lifesciences India Limited's Capital Reinvestment Ratio across 9 annual periods. Check SMSLIFE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for SMS Lifesciences India Limited (2016–2025)
Year-by-year Capital Reinvestment Ratio for SMS Lifesciences India Limited from 2016 to 2025. For live market cap and broader valuation context, see SMSLIFE market cap overview.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.51x | Rs298.10 Million | Rs153.49 Million | ▼ -40.0% |
| 2024 | 0.86x | Rs243.06 Million | Rs208.68 Million | ▼ -74.0% |
| 2023 | 3.30x | Rs1.47K | Rs4.86K | ▲ +226.8% |
| 2021 | 1.01x | Rs351.70 Million | Rs355.56 Million | ▼ -37.0% |
| 2020 | 1.61x | Rs145.47 Million | Rs233.53 Million | ▲ +97.2% |
| 2019 | 0.81x | Rs299.93 Million | Rs244.18 Million | ▲ +86.2% |
| 2018 | 0.44x | Rs80.00 Million | Rs34.97 Million | ▲ +17.3% |
| 2017 | 0.37x | Rs202.60 Million | Rs75.50 Million | ▼ -3.0% |
| 2016 | 0.38x | Rs196.59 Million | Rs75.50 Million | — |